Roberto Zori
Clinical Genetics (M.D.) · Gainesville, FLNPI 1407887250
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (41.5%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Biomarin Pharmaceutical Inc. at 59.7% of the total. Reporting peaked in 2019 at $85,230 and has fallen 84.7% since, to $13,004 in 2025. Among clinical genetics (m.d.) clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 195 payments — averaging $865.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biomarin Pharmaceutical Inc.$101K
- Amgen$31K
- PTC Therapeutics, Inc.$29K
- Tanabe Pharma America, Inc.$3K
- Modernatx, Inc.$2K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$2K
- plus $996 from 4 others
Across 170 payments — averaging $6203.54 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biomarin Pharmaceutical Inc.$614K
- PTC Therapeutics, Inc.$292K
- Amgen$58K
- Ultragenyx Pharmaceutical Inc.$29K
- Sanofi$28K
- Sanofi US Services Inc.$20K
- plus $13K from 1 others
What the payments were for
- Consulting fees$33,88920%
- Speaking & faculty fees$69,93341%
- Grants$980%
- Travel & lodging$40,82224%
- Food & beverage$4,5453%
- Education$19,40012%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biomarin Pharmaceutical Inc. | 78 | $100,674 |
| Amgen | 36 | $30,699 |
| PTC Therapeutics, Inc. | 40 | $29,437 |
| Tanabe Pharma America, Inc. | 5 | $2,875 |
| Modernatx, Inc. | 20 | $2,278 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 12 | $1,729 |
| Cycle Pharmaceuticals Inc | 1 | $600 |
| Amryt Pharma Holdings Ltd | 1 | $320 |
| Sanofi | 1 | $45 |
| Ultragenyx Pharmaceutical Inc. | 1 | $31 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$168,687 in reported general payments places this provider in the 95th percentile of 37 clinical genetics (m.d.) providers in Florida.
Other clinical genetics (m.d.) in Gainesville
- Klaas WierengaGainesville$5K
- Daniel DriscollGainesville$189
- Charles WilliamsGainesville$154
- Amarilis Sanchez ValleTampa$166K
- Paldeep AtwalWest Palm Beach$121K
- Parul JayakarMiami$82K
- Deborah BarbouthMiami$40K
- Ingrid CristianOrlando$38K
- Maria DescartesFort Myers$9K
- Irman ForghaniMiami$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.